Xylem Inc. Q3 FY2026 earnings call

• Strategic Portfolio Shift: Announced intent to divest Applied Water International and Specialty Flow Control, reducing exposure to non-core markets and lowering China revenue risk from ~2% to ~1%. These businesses represent ~9% of revenue but <5% of EBITDA.
• Segment Reorganization: Transitioning from four segments to three effective 2027 to better align with customer workflows (moving water, treating water, measuring water) and unlock R&D/operating synergies.
• Order Strength vs. Revenue Timing: Orders rose 10% YoY, with MCS up 30% and AW up 15%. Backlog grew 13% to $5.5 billion. However, revenue missed expectations due to deferred utility spending on discretionary items (metering) and slower conversion of WSS capital projects.
• Operational Excellence: Delivered Q3 EBITDA margin of 23.9%, up 70 bps YoY, through productivity gains and price realization that offset inflation and volume mix. EPS grew 5% to $1.44.
• High-Growth Verticals: Highlighted significant momentum in AI/data center infrastructure (AW orders up >200%) and secured major wins in semiconductor ultra-pure water treatment, validating the strategic pivot toward higher-margin industrial verticals.

Measurement and Control Solutions (MCS): Revenue decreased 5% year-over-year, driven by softness in electric metering and analytics. This segment contributed to the overall revenue decline despite strong order growth. Water Infrastructure (WI): Revenue declined 1%, as growth in transport was offset by lower treatment revenue due to delays and '80-20' walk-away actions amid China headwinds. Applied Water (AW): Revenue grew 9%, primarily driven by strength in U.S. commercial buildings and data centers. Water Solutions & Services (WSS): Revenue declined 2%, impacted by slower-than-anticipated large capital project execution and a high-comparison prior year quarter.

• Full-Year 2026 Revenue: Lowered guidance; reported revenue now expected to be down ~1% YoY at $8.95 billion, with organic revenue roughly flat. Previous guidance was 2-3% growth.
• Full-Year 2026 EPS: Reduced to $5.40–$5.45, down from previous guidance of $5.55–$5.70, reflecting lower volume while maintaining margin discipline.
• Full-Year 2026 EBITDA Margin: Maintained expectation of ~23.2%, representing ~100 bps expansion YoY.
• Q4 2026 Revenue: Expects reported revenue to decline ~5% and organic revenue to decline 1-2%.
• Q4 2026 EPS: Guidance set at $1.39–$1.44.
• Q4 2026 EBITDA Margin: Expected to be ~24.5%, up 130 bps YoY, driven by price and productivity.
• Free Cash Flow: Expects FCF margin of ~10.2% for the full year, at the low end of prior ranges, due to higher interest costs and working capital investments.

• Utility Affordability Pressures: Rising construction, energy, and financing costs are causing utilities to defer discretionary purchases, particularly in short-cycle water metering replacement.
• Project Timing Delays: Large capital projects in WSS and municipal treatment are ramping slower than anticipated, pushing revenue recognition into later periods (2028+).
• China Headwinds: Continued challenges in the Chinese market impacting WI order intake and revenue, though mitigated by portfolio rotation.
• Margin Dilution in Growth Areas: Rapid investment in high-growth areas like data centers may temporarily impact margins before normalizing to standard levels.

Q: Analyst asked about the dichotomy between strong Q3 orders and softer near-term revenue conversion, specifically regarding timing normalization in 2027. / A: Management clarified that demand is healthy but converting slower. MCS projects booked in Q3 are scheduled for late 2027/2028. WSS funnel is strong, but large project conversion pace determines cadence. They expect a step-up from Q3 to Q4, with 2027 showing durable transport and improving treatment, while MCS/WSS remain variable based on project timing rather than lost demand.

Q: Analyst inquired about the strategic rationale for resegmentation from four to three divisions and potential customer confusion. / A: CEO explained the new structure aligns with how customers buy (move, treat, measure, optimize). It eliminates overlap where multiple segment presidents attended single meetings. It unlocks R&D synergies (e.g., casting in-sourcing) and reduces support costs. The 80/20 split shows 80% of customers buy from one division; the structure simplifies engagement without complicating solutions via enterprise selling teams for the remaining 20%.

Q: Analyst questioned the sustainability and future growth drivers of the data center opportunity beyond immediate equipment sales. / A: Management noted direct water usage at data centers is limited due to air-cooling trends. The bigger opportunity lies in the broader AI ecosystem, specifically semiconductor fabs (where Xylem has recent wins) and power generation (nuclear legacy expertise). Power projects, requiring significant water, are key long-term drivers for 2028-2030, positioning Xylem well for critical infrastructure needs.

Q: Analyst asked about the impact of affordability concerns on specific product segments and the municipal funding picture. / A: CEO stated municipal demand is fundamentally healthy but cautious. Discretionary deferrals are visible in metering (short-cycle replacements). Treatment demand remains strong but slows due to contractor availability and bidding processes (CMAR). Crucially, US utility capex exposure is <10% of revenue, mostly repair-and-replace which cannot be deferred, supporting durable transport orders.

Q: Analyst sought details on the financial profile and strategic fit of the divested businesses (AWI and Specialty Flow Control). / A: CFO highlighted these units contribute ~9% of revenue but <5% of EBITDA, diluting overall margins. Their revenue growth is negative this year. Divesting them reduces China exposure from 2% to 1% and allows proceeds to fund higher-margin acquisitions or share repurchases, sharpening focus on core growth verticals.